Family Office Of America (FOFA) Operating Income Growth (1y) (2022 - 2026)
Family Office Of America (FOFA) Operating Income Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.51 Bn | 174.22 Bn | 6.27 Bn | -20.56% |
| 2 | Stryker | 128.20 Bn | 125.32 Bn | 3.81 Bn | 11.83% |
| 3 | Medtronic | 107.69 Bn | 98.47 Bn | 6.41 Bn | 30.43% |
| 4 | Boston Scientific | 68.05 Bn | 66.59 Bn | 3.61 Bn | 19.54% |
| 5 | Edwards Lifesciences | 47.52 Bn | 43.85 Bn | 1.29 Bn | 20.97% |
| 6 | GE HealthCare Technologies | 28.46 Bn | 26.17 Bn | 1.98 Bn | -18.12% |
| 7 | Dexcom | 28.25 Bn | 27.13 Bn | 750.30 Mn | 90.95% |
| 8 | Smith & Nephew | 26.73 Bn | 26.15 Bn | - | - |
| 9 | Koninklijke Philips | 25.31 Bn | 22.19 Bn | 2.07 Bn | 74.18% |
| 10 | Family Office Of America | 27.22 Mn | 26.88 Mn | 783,126.00 | 366.04% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 366.04% |
| Dec 31, 2025 | -737.20% |
| Sep 30, 2025 | -157.34% |
| Jun 30, 2025 | -229.94% |
| Mar 31, 2025 | -539.36% |
| Dec 31, 2024 | -101.91% |
| Sep 30, 2024 | 24.97% |
| Jun 30, 2024 | 98.16% |
| Mar 31, 2024 | 79.75% |
| Dec 31, 2023 | 906.36% |
| Sep 30, 2023 | 77.44% |
| Jun 30, 2023 | -221.21% |
| Mar 31, 2023 | 16.05% |
| Dec 31, 2022 | 22.60% |
| Sep 30, 2022 | 75.59% |
| Jun 30, 2022 | 18.02% |